In a 65-year-old diabetic male with a weeping foul ulcer at the nape and severe facial swelling limiting eye opening, who is receiving meropenem for cellulitis and has a serum creatinine of 1.8 mg/dL, should amikacin be replaced with levofloxacin and what levofloxacin dose is appropriate for his renal function?

Should Amikacin Be Switched to Levofloxacin?

No, amikacin should NOT be switched to levofloxacin in this patient with worsening renal function (creatinine 1.8 mg/dL from 1.6 mg/dL). Instead, amikacin should be dose-adjusted and given at extended intervals (three times weekly) rather than discontinued, while continuing meropenem.

Rationale for Continuing Amikacin

This patient has a severe necrotizing soft tissue infection (evidenced by foul-smelling ulcer, severe facial swelling, fat stranding on CT, persistent fever despite meropenem, and rising WBC from 23K to 25K on day 8). For serious skin and soft tissue infections, particularly in diabetic patients where polymicrobial and resistant organisms are common, amikacin remains the most active parenteral agent and should be continued with appropriate dose adjustment 1.

The rising WBC and persistent fever despite meropenem suggest either:

• Inadequate source control
• Resistant organisms requiring dual therapy
• Possible atypical organisms (including mycobacteria given the "weeping furuncle" description)

Amikacin Dosing in Renal Impairment

With creatinine 1.8 mg/dL (estimated CrCl approximately 30-40 mL/min in a 65-year-old male), amikacin should be dosed at 12-15 mg/kg three times weekly (not daily) to maintain efficacy while minimizing nephrotoxicity 2, 3, 2, 4.

Key dosing principles:

• Do NOT reduce the individual dose - maintain 12-15 mg/kg per dose to achieve concentration-dependent killing 2
• Extend the dosing interval to 2-3 times weekly 2, 3, 2
• Administer after any dialysis sessions if applicable 2
• Monitor peak levels (target 35-45 μg/mL for daily dosing, 65-80 μg/mL for intermittent dosing) and trough levels (<5 mg/L) 3, 2

The FDA label confirms: "For persons greater than 59 years of age the dose should be reduced to 10 mg/kg per day (750 mg). The dosing frequency should be reduced (i.e., 12-15 mg/kg per dose, two or three times per week) in persons with renal insufficiency" 4.

Why NOT Levofloxacin?

Levofloxacin is contraindicated as a replacement in this clinical scenario for several reasons:

1. Worsening renal function: With creatinine 1.8 mg/dL (CrCl <30 mL/min), levofloxacin requires dose reduction to 750-1000 mg three times weekly 2. This provides LESS coverage than properly dosed amikacin.

2. Inferior activity: Levofloxacin has significantly lower activity against the likely polymicrobial pathogens in diabetic necrotizing soft tissue infections compared to amikacin, particularly against:

   • Pseudomonas aeruginosa (common in diabetic foot/soft tissue infections) 5, 6
   • Resistant gram-negative organisms
   • Potential atypical mycobacteria (given the "weeping furuncle" description) 1

3. Monotherapy inadequacy: The minimal pus drainage despite severe clinical presentation suggests either inadequate source control or resistant/atypical organisms requiring combination therapy with amikacin + meropenem 1, 7, 8.

Meropenem Dosing Verification

Ensure meropenem is appropriately dosed for this patient's renal function. With creatinine 1.8 mg/dL:

• If CrCl 26-50 mL/min: meropenem 1g every 12 hours 9
• If CrCl 10-25 mL/min: meropenem 500mg every 12 hours 9

Consider extended infusion (3-4 hours) or continuous infusion of meropenem to optimize time above MIC, especially if resistant organisms are suspected 10, 11, 12.

Critical Next Steps

1. Reassess source control urgently - minimal pus drainage with severe clinical presentation suggests inadequate drainage or necrotizing infection requiring surgical debridement 7, 8

2. Obtain cultures - blood cultures and deep tissue cultures (not superficial swabs) to guide definitive therapy 7, 8

3. Adjust amikacin: Switch to 12-15 mg/kg three times weekly with peak/trough monitoring 2, 3, 2, 4

4. Monitor renal function closely - daily creatinine, consider nephrology consultation if further deterioration 2, 4

5. Consider imaging-guided drainage if no clinical improvement within 48-72 hours 7, 8

Common Pitfalls to Avoid

• Do NOT simply discontinue amikacin due to rising creatinine - adjust the interval instead 2
• Do NOT reduce the individual amikacin dose below 12 mg/kg - this compromises efficacy 2
• Do NOT switch to fluoroquinolones in severe necrotizing infections requiring dual gram-negative coverage 1, 7
• Do NOT continue current therapy beyond 48-72 hours without reassessing source control if no clinical improvement 7, 8